Certis Oncology Solutions
San Diego
About Certis Oncology Solutions
Certis is a precision oncology and translational science company. Our product is Oncology Intelligence®’highly predictive therapeutic response data derived from advanced models of cancer. Certis partners with oncology therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Using CertisAI™, our proprietary artificial intelligence/machine learning platform, and more clinically relevant, patient-derived tumor models, we bring certainty to lead candidate selection and help secure clear and compelling evidence of drug efficacy. Certis is ALAAAC-accredited and CLIA-certified for high-complexity testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $10.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2024)
- Website: certisoncology.com
- Phone: 858-952-1820
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/certis-oncology-solutions-6326 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.